Home Cart Sign in  
Chemical Structure| 50-63-5 Chemical Structure| 50-63-5

Structure of Chloroquine phosphate
CAS No.: 50-63-5

Chemical Structure| 50-63-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. It is an autophagy and toll-like receptor (TLR) inhibitor and is highly effective in controlling SARS-CoV-2 (COVID-19) infection in vitro (EC50 = 1.13 μM).

Synonyms: Chloroquine(phosphate)(CRM); Chloroquine diphosphate; NSC 14050

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Perez, Celia N. ; Falcon, Cristian R. ; Mons, Johinna Delgado ; Orlandi, Federico Cuello ; Sangiacomo, Mercedes ; Fernandez-Munoz, Juan M. , et al.

Abstract: Over the last years, the incidence of melanoma, the deadliest form of skin cancer, has risen significantly. Nearly half of the melanoma patients exhibit the BRAFV600E mutation. Although the use of BRAF and MEK inhibitors (BRAFi and MEKi) showed an impressive success rate in melanoma patients, durability of response remains an issue because tumor quickly becomes resistant. Here, we generated and characterized Lu1205 and A375 melanoma cells resistant to vemurafenib (BRAFi). Resistant cells (Lu1205R and A375R) exhibit higher IC50 (5-6 fold increase) and phospho-ERK levels and 2-3 times reduced apoptosis than their sensitive parents (Lu1205S and A375S). Moreover, resistant cells are 2-3 times bigger, display a more elongated morphol. and have a modulation of migration capacity. Interestingly, pharmacol. inhibition of sphingosine kinases, that prevents sphingosine-1-phosphate production, reduces migration of Lu1205R cells by 50%. In addition, although Lu1205R cells showed increased basal levels of the autophagy markers LC3II and p62, they have decreased autophagosome degradation and autophagy flux. Remarkably, expression of Rab27A and Rab27B, which are involved in the release of extracellular vesicles are dramatically augmented in resistant cells (i.e. 5-7 fold increase). Indeed, conditioned media obtained from Lu1205R cells increased the resistance to vemurafenib of sensitive cells. Hence, these results support that resistance to vemurafenib modulates migration and the autophagic flux and may be transferred to nearby sensitive melanoma cells by factors that are released to the extracellular milieu by resistant cells.

Keywords: Melanoma ; BRAF V600E mutation ; Vemurafenib ; Autophagy ; Resistance transfer

Purchased from AmBeed:

Alternative Products

Product Details of Chloroquine phosphate

CAS No. :50-63-5
Formula : C18H32ClN3O8P2
M.W : 515.86
SMILES Code : CC(NC1=CC=NC2=CC(Cl)=CC=C12)CCCN(CC)CC.O=P(O)(O)O.O=P(O)(O)O
Synonyms :
Chloroquine(phosphate)(CRM); Chloroquine diphosphate; NSC 14050
MDL No. :MFCD00069852

Safety of Chloroquine phosphate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Chloroquine phosphate

DNA
PI3K-AKT

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.69mL

1.94mL

0.97mL

19.39mL

3.88mL

1.94mL

References

 

Historical Records

Categories